Prelude Therapeutics Incorporated - Common Stock (NQ:PRLD)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 3.960 |
| Bid (Size) | 3.960 (600) |
| Ask (Size) | 4.120 (1,000) |
| Prev. Close | 3.960 |
| Today's Range | 3.960 - 3.960 |
| 52wk Range | 1.150 - 6.830 |
| Shares Outstanding | 54,808,715 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Which stocks are gapping on Tuesday? ↗
July 28, 2026
The $71 Billion Cancer Shift: Why The FDA Is Speeding Up
February 05, 2026
Why Did PRLD Stock Surge 13% Today? ↗
February 03, 2026
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
November 13, 2025
Frequently Asked Questions
Is Prelude Therapeutics Incorporated - Common Stock publicly traded?
Yes, Prelude Therapeutics Incorporated - Common Stock is publicly traded.
What exchange does Prelude Therapeutics Incorporated - Common Stock trade on?
Prelude Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Prelude Therapeutics Incorporated - Common Stock?
The ticker symbol for Prelude Therapeutics Incorporated - Common Stock is PRLD on the Nasdaq Stock Market
What is the current price of Prelude Therapeutics Incorporated - Common Stock?
The current price of Prelude Therapeutics Incorporated - Common Stock is 3.960
When was Prelude Therapeutics Incorporated - Common Stock last traded?
The last trade of Prelude Therapeutics Incorporated - Common Stock was at 09/29/26 04:00 PM ET
What is the market capitalization of Prelude Therapeutics Incorporated - Common Stock?
The market capitalization of Prelude Therapeutics Incorporated - Common Stock is 217.04M
How many shares of Prelude Therapeutics Incorporated - Common Stock are outstanding?
Prelude Therapeutics Incorporated - Common Stock has 217M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.